Nkgen Biotech, Inc.
Clinical trials sponsored by Nkgen Biotech, Inc., explained in plain language.
-
Could your own immune cells fight Alzheimer's? new trial launches
Disease control Recruiting nowThis early-stage trial is testing whether a personalized natural killer (NK) cell therapy called SNK01 is safe and might help people with moderate Alzheimer's disease. The treatment is made from each patient's own immune cells and given as an IV infusion every three weeks for up …
Phase: PHASE1, PHASE2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could immune cells fight Alzheimer's? new study tests Long-Term safety
Disease control Recruiting nowThis study is testing the long-term safety of SNK01, a personalized therapy made from a patient's own natural killer cells, in 30 people with Alzheimer's disease. It is an extension of an earlier trial and aims to see if the treatment is safe and tolerable over time. Researchers …
Phase: PHASE2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC